BBHC
CVS icon

Brown Brothers Harriman & Co’s CVS Health CVS Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Buy
36,029
+18,576
+106% +$1.66M 0.02% 252
2026
Q1 		$1.25M Buy
17,453
+4,261
+32% +$328K 0.01% 383
2025
Q4 		$1.05M Buy
13,192
+3,424
+35% +$270K 0.01% 365
2025
Q3 		$736K Buy
9,768
+2,524
+35% +$173K ﹤0.01% 404
2025
Q2 		$500K Buy
7,244
+3,687
+104% +$242K ﹤0.01% 458
2025
Q1 		$241K Buy
3,557
+1,054
+42% +$63.1K ﹤0.01% 519
2024
Q4 		$112K Sell
2,503
-3,088
-55% -$173K ﹤0.01% 697
2024
Q3 		$352K Sell
5,591
-662
-11% -$38.6K ﹤0.01% 475
2024
Q2 		$369K Sell
6,253
-5,819
-48% -$364K ﹤0.01% 418
2024
Q1 		$963K Buy
12,072
+1,113
+10% +$85K 0.01% 271
2023
Q4 		$865K Sell
10,959
-8,584
-44% -$611K 0.01% 277
2023
Q3 		$1.36M Buy
19,543
+6,436
+49% +$456K 0.01% 216
2023
Q2 		$906K Sell
13,107
-3,040
-19% -$216K 0.01% 260
2023
Q1 		$1.2M Buy
16,147
+2,604
+19% +$218K 0.01% 228
2022
Q4 		$1.26M Sell
13,543
-293
-2% -$28.3K 0.01% 196
2022
Q3 		$1.32M Buy
13,836
+2,097
+18% +$208K 0.01% 188
2022
Q2 		$1.09M Buy
11,739
+869
+8% +$84.8K 0.01% 206
2022
Q1 		$1.1M Sell
10,870
-2,355
-18% -$247K 0.01% 235
2021
Q4 		$1.36M Buy
13,225
+1,871
+16% +$173K 0.01% 207
2021
Q3 		$964K Buy
11,354
+3,066
+37% +$257K 0.01% 230
2021
Q2 		$692K Sell
8,288
-70,843
-90% -$5.8M ﹤0.01% 280
2021
Q1 		$5.95M Sell
79,131
-1,237
-2% -$90.1K 0.04% 106
2020
Q4 		$5.49M Buy
80,368
+3,836
+5% +$250K 0.04% 107
2020
Q3 		$4.47M Sell
76,532
-1,765
-2% -$110K 0.03% 105
2020
Q2 		$5.09M Buy
78,297
+167
+0.2% +$10.5K 0.04% 94
2020
Q1 		$4.63M Sell
78,130
-6,492
-8% -$433K 0.04% 95
2019
Q4 		$6.29M Buy
84,622
+5,120
+6% +$360K 0.04% 101
2019
Q3 		$5.01M Buy
79,502
+1,385
+2% +$82.1K 0.03% 110
2019
Q2 		$4.26M Sell
78,117
-855
-1% -$46K 0.03% 113
2019
Q1 		$4.26M Buy
78,972
+1,286
+2% +$79.4K 0.03% 113
2018
Q4 		$5.09M Sell
77,686
-2,380
-3% -$178K 0.04% 101
2018
Q3 		$6.3M Buy
80,066
+3,600
+5% +$257K 0.04% 90
2018
Q2 		$4.92M Buy
76,466
+39,353
+106% +$2.59M 0.03% 100
2018
Q1 		$2.31M Sell
37,113
-1,669
-4% -$120K 0.01% 130
2017
Q4 		$2.81M Sell
38,782
-35
-0.1% -$2.54K 0.02% 125
2017
Q3 		$3.16M Sell
38,817
-1,106
-3% -$87.5K 0.02% 112
2017
Q2 		$3.21M Sell
39,923
-3,092
-7% -$244K 0.02% 107
2017
Q1 		$3.38M Sell
43,015
-321
-0.7% -$25.6K 0.02% 107
2016
Q4 		$3.42M Buy
43,336
+3,154
+8% +$255K 0.02% 107
2016
Q3 		$3.58M Sell
40,182
-142
-0.4% -$13.4K 0.02% 107
2016
Q2 		$3.86M Sell
40,324
-16,256
-29% -$1.62M 0.02% 105
2016
Q1 		$5.87M Sell
56,580
-360
-0.6% -$35K 0.03% 94
2015
Q4 		$5.57M Sell
56,940
-384
-0.7% -$37.6K 0.03% 99
2015
Q3 		$5.53M Sell
57,324
-147
-0.3% -$15.5K 0.03% 99
2015
Q2 		$6.03M Buy
57,471
+500
+0.9% +$51.1K 0.03% 91
2015
Q1 		$5.88M Buy
56,971
+52,181
+1,089% +$5.28M 0.03% 95
2014
Q4 		$461K Sell
4,790
-1,553
-24% -$137K ﹤0.01% 266
2014
Q3 		$505K Buy
6,343
+4,181
+193% +$330K ﹤0.01% 261
2014
Q2 		$163K Sell
2,162
-901
-29% -$68.1K ﹤0.01% 375
2014
Q1 		$229K Sell
3,063
-2,051
-40% -$145K ﹤0.01% 318
2013
Q4 		$366K Buy
5,114
+3,651
+250% +$235K ﹤0.01% 330
2013
Q3 		$83K Sell
1,463
-3,716
-72% -$221K ﹤0.01% 414
2013
Q2 		$296K Buy
+5,179
New +$300K ﹤0.01% 343

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Brown Brothers Harriman & Co's CVS Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its CVS Health (CVS) stake by 106% in Q2 2026, buying an estimated $1.66M and bringing the position to 36,029 shares worth $3.73M. The position accounts for 0.02% of the portfolio, ranked #252.

Brown Brothers Harriman & Co first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.3M in Q3 2018. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Brown Brothers Harriman & Co held 36,029 shares of CVS Health worth $3.73M as of Q2 2026.
  • Brown Brothers Harriman & Co bought 18,576 CVS Health shares in Q2 2026, an estimated $1.66M.
  • CVS Health made up 0.02% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #252 holding.
  • Brown Brothers Harriman & Co first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Brown Brothers Harriman & Co's CVS Health position peaked at $6.3M in Q3 2018.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.